Results 141 to 150 of about 38,754 (285)
Emerging Nanonutraceuticals against Obesity
This overview comprehensively compiles the latest research advancements in diversiform nanonutraceuticals against obesity. These nanonutraceuticals are derived from the nanomodifications of some carbohydrates, lipids, proteins, vitamins, minerals, and phytochemicals.
Linjie Ni+8 more
wiley +1 more source
Abstract Background Pheochromocytoma is a rare catecholamine‐secreting tumor that often presents with symptoms such as hypertension, palpitations, and sweating due to excessive hormone production. In some cases, the catecholamine‐induced vasoconstriction and hypercoagulability associated with pheochromocytomas can lead to cerebrovascular accidents and ...
Mohannad N. AbuHaweeleh+6 more
wiley +1 more source
A paper‐based bi‐enzymatic sensor for chemiresistive glucose detection
This paper presents the development of a paper‐based glucose sensor utilizing poly(3,4‐ethylene‐dioxythiophene) polystyrene sulfonate (PEDOT:PSS) and a bi‐enzymatic system with Horseradish Peroxidase (HRP) and Glucose Oxidase (GOx). The chemiresistive sensor is optimized for detecting glucose in biofluids such as saliva, requiring only 40 µL of sample ...
Riccardo Zulli+7 more
wiley +1 more source
Interventional oncology in children: Where are we now?
Abstract Paediatric Interventional Oncology (IO) lags behind adult IO due to a scarcity of specific outcome data. The suboptimal way to evolve this field is relying heavily on adult experiences. The distinct tumour types prevalent in children, such as extracranial germ cell tumours, sarcomas, and neuroblastoma, differ strongly from those found in ...
Premal Amrishkumar Patel+1 more
wiley +1 more source
Data were included from adolescents with moderate‐to‐severe AD treated with the JAK1 inhibitor abrocitinib (200 mg/100 mg) across JADE clinical trials. Improvements in skin clearance (per EASI‐75) and itch (per PP‐NRS4) were maintained for up to 112 weeks with both abrocitinib doses.
Amy S. Paller+13 more
wiley +1 more source
FAT EMBOLISM AS A POSTOPERATIVE COMPLICATION OF EXTRAPLEURAL THORACOPLASTY
B.N. Carter+2 more
openalex +1 more source
Clofibrate and Fat Embolism: A Double-Blind Trial of the Effects of Clofibrate on Sequelae to Injury [PDF]
William G. Cole
openalex +1 more source
Abstract Introduction Testosterone therapy has become a cornerstone treatment for men with hypogonadism, offering significant benefits such as improved sexual function, mood, muscle mass, and bone density. However, concerns about its cardiovascular safety have historically tempered its use.
Michael Zitzmann+15 more
wiley +1 more source
Nutritional secondary hyperparathyroidism is a metabolic disorder caused by an imbalance in calcium homeostasis and is typically associated with the feeding of a calcium‐deficient diet. Nutritional secondary hyperparathyroidism has been reported in domestic species, including cats and dogs, as well as captive carnivores and wildlife including lions ...
JL Austen+5 more
wiley +1 more source
Clinical Utility of Intra-Operative 6 Hydroxyethyl Starch (130 / 0.4) Supplementation in Hypoxemic Femur Injury Patients: A Preliminary Report of Twenty Cases [PDF]
: Posttraumatic intravasation of fat and debris can lead to a cascade of events. Hydroxyethyl starches (HES) markedly suppress neutrophil influx by decreasing pulmonary capillary permeability and facilitating tissue oxygenation by improving ...
Das Puri, G.+3 more
core